Mettler-Toledo International Investor Presentation — May 2024

Document content

Mettler -Toledo International Inc.Earnings Call Webcast

Q1 2024 Financial Results

Safe Harbor Statement 2

Statements in this presentation which are not historical facts constitute “forward looking statements” within the meaning of

Section 27A of the U.S. Securities Act of 1933 and Section 21E of the U.S. Securities Exchange Act of 1934. These statements involve known and unknown risks, uncertainties and other factors that may cause our or our businesses, actual

results, levels of activity, performance or achievements to be materially different from those expressed or implied by any

forward- looking statements. For a discussion of these risks and uncertainties, please see "Factors Affecting Our Future

Operating Results" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10- K for the most recently completed fiscal year and other reports filed with the SEC from time to

time.Summary Comments

First Quarter 2024 Highlights

Our first quarter results were much better than expected,

although we continued to face reduced market demand,

especially in China, versus the prior year. We also substantially

recovered our previously disclosed delayed product shipments from the fourth quarter of 2023, slightly better than forecast.

Strong execution of our productivity and cost savings initiatives offset significant foreign exchange headwinds and resulted in modest Adjusted EPS growth in the quarter.

We expect soft market conditions in the second quarter of 2024, particularly in China. We remain focused on the diligent

execution of our growth strategies, while continuing to drive

innovation and further strengthen our Company for the future. 3

Above: Our new EVA titrators are ideal for efficiently determining the water

content of challenging samples, and our new control algorithm speeds up reaction rates for faster analyses and cycle times. An automated solvent exchange system ensures safety by minimizing exposure to chemicals. EVA titrators have full compatibility with LabX to enable error -free data

transfer for secure, compliant, and audit -ready workflows.Sales by Geography

Q1 local currency sales growth

(8%) LC$929 $9267% LC 0% LC41% 30% 29%

1Q23 1Q24 1Q23 1Q24 1Q23 1Q24 1Q23 1Q24Americas Europe Total Asia/ROW4

USD in 000's, figures may not foot due to rounding. Local currency (LC) sales growth excludes the impact from changes in foreign exchange rates. Excluding the

benefit from recovering delayed Q4 shipments, LC sales declined about (6%) in Q1 2024 with the Americas (1%), Europe (5%), and A sia/ROW (12%). $520 $525